Search results
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 8 hours agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company sells. There ...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days ago“We continue to have active conversations with both manufacturers, and the negotiations are...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 3 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 4 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 4 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 2 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday ...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 3 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 4 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
AOL· 2 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator told vaccine makers ...